0.1050
0.0000
(0.00%)
As of January 29 at 8:00:22 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-30,272.0000
-22,608.0000
-26,240.0000
-23,573.0000
-23,206.0000
Investing Cash Flow
-2,178.0000
1,444.0000
4,006.0000
-38,224.0000
16,668.0000
Financing Cash Flow
33,507.0000
15,056.0000
20,438.0000
57,749.0000
17,866.0000
End Cash Position
8,784.0000
4,255.0000
10,587.0000
12,990.0000
16,831.0000
Interest Paid Supplemental Data
1,864.0000
1,111.0000
593.0000
682.0000
994.0000
Capital Expenditure
-77.0000
-297.0000
-316.0000
-97.0000
--
Issuance of Capital Stock
17,551.0000
14,089.0000
14,359.0000
50,407.0000
19,246.0000
Issuance of Debt
19,223.0000
--
9,126.0000
--
--
Repayment of Debt
-3,704.0000
-1,988.0000
-3,052.0000
-3,572.0000
-3,357.0000
Free Cash Flow
-30,349.0000
-22,905.0000
-26,556.0000
-23,670.0000
-23,206.0000
12/31/2020 - 11/17/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2UV.F Applied Therapeutics, Inc.
0.5710
+10.87%
3G0.BE Altimmune Inc
6.63
-1.19%
NV4.F Cellectar Biosciences, Inc.
0.2160
+8.00%
8AW0.F Ocean Biomedical, Inc.
0.1940
-11.82%
M55.F MacroGenics, Inc.
2.8800
-0.48%
8AW0.BE Ocean Biomedical Inc
0.1920
+6.08%
AT20.F Atara Biotherapeutics, Inc.
8.30
+11.41%
0M4.DU Mersana Therapeutics Inc
0.5924
+0.30%
1VT.DU Viking Therapeutics Inc
33.25
+3.42%
2UV.DU Applied Therapeutics Inc
0.5825
+1.39%